Huons Co., Ltd. (KOSDAQ:243070)

South Korea flag South Korea · Delayed Price · Currency is KRW
28,600
-1,950 (-6.38%)
Jun 10, 2026, 3:30 PM KST
Market Cap355.96B +11.5%
Revenue (ttm)616.80B +4.8%
Net Income30.69B -3.7%
EPS2,611.50 -0.4%
Shares Out 11.65M
PE Ratio11.70
Forward PEn/a
Dividend920.00 (3.43%)
Ex-Dividend DateMay 26, 2026
Volume34,633
Open30,200
Previous Close30,550
Day's Range28,100 - 30,950
52-Week Range24,550 - 41,500
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateMay 12, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic... [Read more]

Sector Healthcare
Founded 1965
Employees 912
Stock Exchange KOSDAQ
Ticker Symbol 243070
Full Company Profile

Financial Performance

In 2025, Huons's revenue was 620.77 billion, an increase of 5.17% compared to the previous year's 590.23 billion. Earnings were 42.66 billion, an increase of 44.84%.

Financial Statements